129 related articles for article (PubMed ID: 3141208)
1. Treatment of pure red cell aplasia with ciclosporin: suppression of activated T suppressor/cytotoxic and NK-like cells in marrow and blood correlates with haematological response.
Tötterman TH; Bengtsson M
Eur J Haematol; 1988 Sep; 41(3):204-11. PubMed ID: 3141208
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporin A in the treatment of CLL associated PRCA and bone marrow hypoplasia.
Tura S; Finelli C; Bandini G; Cavo M; Gobbi M
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):479-81. PubMed ID: 3146746
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporin-A for the treatment of pure red cell aplasia in a patient with chronic lymphocytic leukemia.
Chikkappa G; Pasquale D; Phillips PG; Mangan KF; Tsan MF
Am J Hematol; 1987 Oct; 26(2):179-89. PubMed ID: 3116843
[TBL] [Abstract][Full Text] [Related]
4. Treatment of pure red-cell aplasia and aplastic anaemia with ciclosporin: long-term clinical effects.
Tötterman TH; Höglund M; Bengtsson M; Simonsson B; Almqvist D; Killander A
Eur J Haematol; 1989 Feb; 42(2):126-33. PubMed ID: 2492947
[TBL] [Abstract][Full Text] [Related]
5. Regeneration of functional and activated NK and T sub-subset cells in the marrow and blood after autologous bone marrow transplantation: a prospective phenotypic study with 2/3-color FACS analysis.
Bengtsson M; Tötterman TH; Smedmyr B; Festin R; Oberg G; Simonsson B
Leukemia; 1989 Jan; 3(1):68-75. PubMed ID: 2535882
[TBL] [Abstract][Full Text] [Related]
6. Pure red cell aplasia associated with expansion of CD3+ CD8+ granular lymphocytes expressing cytotoxicity against HLA-E+ cells.
Mori KL; Furukawa H; Hayashi K; Sugimoto KJ; Oshimi K
Br J Haematol; 2003 Oct; 123(1):147-53. PubMed ID: 14510958
[TBL] [Abstract][Full Text] [Related]
7. Pure red cell aplasia: lymphocyte inhibition of erythropoiesis.
Abkowitz JL; Kadin ME; Powell JS; Adamson JW
Br J Haematol; 1986 May; 63(1):59-67. PubMed ID: 3085703
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine restores hematopoietic function by compensating for decreased Tregs in patients with pure red cell aplasia and acquired aplastic anemia.
Dao AT; Yamazaki H; Takamatsu H; Sugimori C; Katagiri T; Maruyama H; Zaimoku Y; Maruyama K; Ly TQ; Espinoza L; Nakao S
Ann Hematol; 2016 Apr; 95(5):771-81. PubMed ID: 26968551
[TBL] [Abstract][Full Text] [Related]
9. Aplastic anemia and pure red cell aplasia associated with large granular lymphocyte leukemia.
Go RS; Lust JA; Phyliky RL
Semin Hematol; 2003 Jul; 40(3):196-200. PubMed ID: 12876668
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive mechanisms in pure red cell aplasia--a review.
Nidorf D; Saleem A
Ann Clin Lab Sci; 1990; 20(3):214-9. PubMed ID: 2111653
[TBL] [Abstract][Full Text] [Related]
11. [Cyclosporin for pure red cell aplasia caused rapid improvement of anemia and increase of CD4/8 ratio].
Kaito K; Masuoka H; Kobayashi M; Nishiwaki K; Shimada T; Yoshida M; Ochiai S; Katayama T; Sakai O
Rinsho Ketsueki; 1993 Feb; 34(2):159-64. PubMed ID: 8492414
[TBL] [Abstract][Full Text] [Related]
12. [Role of gammadeltaT cells in pathogenesis of acquired pure red cell aplastic anemia].
Liu M; Liu T; Meng WT; Zhu HL; Cui X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):142-6. PubMed ID: 17490541
[TBL] [Abstract][Full Text] [Related]
13. Pure red cell aplasia: response to therapy with anti-thymocyte globulin.
Abkowitz JL; Powell JS; Nakamura JM; Kadin ME; Adamson JW
Am J Hematol; 1986 Dec; 23(4):363-71. PubMed ID: 3098093
[TBL] [Abstract][Full Text] [Related]
14. Pure red cell aplasia following autoimmune haemolytic anaemia. Cell-mediated suppression of erythropoiesis as a possible pathogenesis of pure red cell aplasia.
Tohda S; Nara N; Tanikawa S; Imai Y; Murakami N; Aoki N
Acta Haematol; 1992; 87(1-2):98-102. PubMed ID: 1585778
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of immune cell trafficking in interferon-beta treated multiple sclerosis patients.
Hartrich L; Weinstock-Guttman B; Hall D; Badgett D; Baier M; Patrick K; Feichter J; Hong J; Ramanathan M
J Neuroimmunol; 2003 Jun; 139(1-2):84-92. PubMed ID: 12799025
[TBL] [Abstract][Full Text] [Related]
16. Serum erythropoietic inhibitors in patients with pure red cell aplasia.
Takahashi M; Nikkuni K; Tanaka I; Furukawa T; Moriyama Y; Shibata A; Satoh S; Kuwabara Y; Maruyama Y; Matsunaga Y
Ann Hematol; 1991 Jul; 63(1):9-14. PubMed ID: 1908708
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure.
Maciejewski JP; Hibbs JR; Anderson S; Katevas P; Young NS
Exp Hematol; 1994 Oct; 22(11):1102-10. PubMed ID: 7925777
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.
Karlsson FA; Tötterman TH
Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281
[TBL] [Abstract][Full Text] [Related]
19. Pure red cell aplasia and thymoma associated with high levels of the suppressor/cytotoxic T lymphocyte subset.
Milnes JP; Goorney BP; Wallington TB
Br Med J (Clin Res Ed); 1984 Nov; 289(6455):1333-4. PubMed ID: 6238646
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporin-A therapy of pure red cell aplasia in a patient with B-cell chronic lymphocytic leukemia.
Christen R; Morant R; Fehr J
Eur J Haematol; 1989 Mar; 42(3):303-7. PubMed ID: 2494058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
